Hadley Celene, Awan Omer Abdulrehman, Zoarski Gregg H
University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA.
Neuroimaging Clin N Am. 2010 May;20(2):159-67. doi: 10.1016/j.nic.2010.02.002.
Percutaneous vertebral augmentation is a successful means of relieving pain and reducing disability after vertebral compression fracture; however, the exact mechanism by which vertebral augmentation eliminates pain remains unproven. Most likely, pain relief is because of stabilization of microfractures. The biomechanical effects of vertebral fracture and subsequent vertebral augmentation therapy, however, are topics for continued investigation. Altered biomechanical stresses after treatment may affect the risk of adjacent fracture in an osteoporotic patient; that risk may be different after vertebral augmentation with cavity creation (balloon assisted vertebroplasty or kyphoplasty) when compared with vertebral augmentation without cavity creation (vertebroplasty). Polymethyl methacrylate cement used in these procedures may have an important effect on the load transfer and disk mechanics, and therefore, the variables of cement volume, formulation, and distribution should also be evaluated. Finally, the question of whether prophylactic treatment of adjacent intact levels is indicated must be considered.
经皮椎体强化术是缓解椎体压缩性骨折后疼痛和减少残疾的一种成功方法;然而,椎体强化术消除疼痛的确切机制仍未得到证实。最有可能的是,疼痛缓解是由于微骨折的稳定。然而,椎体骨折及随后的椎体强化治疗的生物力学效应仍是持续研究的课题。治疗后生物力学应力的改变可能会影响骨质疏松患者相邻椎体骨折的风险;与未形成空腔的椎体强化术(椎体成形术)相比,形成空腔的椎体强化术(球囊辅助椎体成形术或后凸成形术)后这种风险可能有所不同。这些手术中使用的聚甲基丙烯酸甲酯骨水泥可能对负荷传递和椎间盘力学有重要影响,因此,骨水泥体积、配方和分布等变量也应予以评估。最后,必须考虑是否需要对相邻完整节段进行预防性治疗的问题。